British specialty medicines firm Essential Pharma has announced the closing of two transactions with UK-based Rosemont Pharmaceuticals, bringing niche products into its portfolio. Financial terms of the transaction were not revealed.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.